GRIDX is the leading venture capital fund for non-therapeutics biotech startups in Latin America. With a portfolio of 81 startups across 7 countries and over 8 years of experience, we have been pioneers in connecting Latin American science with venture capital through our company-building program.
Each year, we run a discovery and transformation process for scientific and business talent, aiming to co-found startups that develop disruptive solutions based on laboratory-generated knowledge. We invest USD 250,000 in these startups and connect them with the world to help them scale. Additionally, we support their subsequent funding rounds with up to USD 1 million.
Company Details
- Employees
- 20
- Founded
- -
- Address
- Teodoro García 2474, Ciudad Autónoma De Buenos Aires,buenos Aires,argentina
- Phone
- 5491165256850
- in****@****ial.com
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- gridexponential.com
- HQ
- Ciudad Autónoma de Buenos Aires, Buenos Aires
- Competitors
- Caspr Biotech, CITES, ATGen, CyanoMin, gridX, CellRep, SF500, Stämm, BioBlends, MicroIN.
Gridx Questions
Gridx's helpline number is 5491165256850
Gridx's website is gridexponential.com
Gridx's LinkedIn profile is https://ar.linkedin.com/company/grid-exponential
Gridx has
20 employees.
View email and phone details for 20
employees at Gridx.
Gridx's industry is
Venture Capital and Private Equity Principals
Gridx's support email address is info@gridexponential.com
Gridx's categories are Venture Capital and Private Equity Principals
Gridx's founding year is 2017
